EUVIMEDEUVIMED entdecken
Korrektur

Corrigendum to “Achieving an Objective Response Following Two Cycles of Neoadjuvant Chemotherapy Plus Anti-PD-(L)1 Inhibitors Might Predict the Optimal Pathological Response in Resectable Stage II-III Nonsmall Cell Lung Cancer” [Clinical Lung Cancer 26 (2025) 573-582]

Weibo Cao, Hongtao Duan, Changjian Shao, Xiaolong Yan, Honggang Liu

Clinical Lung Cancer · 2026-11 · 27 (9) · 51

DOI: 10.1016/j.cllc.2026.09.008 ↗

Kurz gefasst

Korrektur in der Zeitschrift Clinical Lung Cancer, 2026-11. Verfasst von Weibo Cao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The Second Affiliated Hospital of Air Force Medical University, Xi'an, China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Thoracic Surgery, The Second Affiliated Hospital of Air Force Medical University, Xi'an, China.
  • Department of Thoracic Surgery, The Second Affiliated Hospital of Air Force Medical University, Xi'an, China. Electronic address: yanxiaolong@fmmu.edu.cn.
  • Department of Thoracic Surgery, The Second Affiliated Hospital of Air Force Medical University, Xi'an, China. Electronic address: drliuhg@163.com.

Zitieren

APA

Cao, W., Duan, H., Shao, C., Yan, X., & Liu, H. (2026). Corrigendum to “Achieving an Objective Response Following Two Cycles of Neoadjuvant Chemotherapy Plus Anti-PD-(L)1 Inhibitors Might Predict the Optimal Pathological Response in Resectable Stage II-III Nonsmall Cell Lung Cancer” [Clinical Lung Cancer 26 (2025) 573-582]. Clinical Lung Cancer, 27(9), 51. https://doi.org/10.1016/j.cllc.2026.09.008

Vancouver

Cao W, Duan H, Shao C, Yan X, Liu H. Corrigendum to “Achieving an Objective Response Following Two Cycles of Neoadjuvant Chemotherapy Plus Anti-PD-(L)1 Inhibitors Might Predict the Optimal Pathological Response in Resectable Stage II-III Nonsmall Cell Lung Cancer” [Clinical Lung Cancer 26 (2025) 573-582]. Clinical Lung Cancer. 2026;27(9):51. doi:10.1016/j.cllc.2026.09.008

BibTeX
@article{Cao2026,
  author = {Cao, Weibo and Duan, Hongtao and Shao, Changjian and Yan, Xiaolong and Liu, Honggang},
  title = {Corrigendum to “Achieving an Objective Response Following Two Cycles of Neoadjuvant Chemotherapy Plus Anti-PD-(L)1 Inhibitors Might Predict the Optimal Pathological Response in Resectable Stage II-III Nonsmall Cell Lung Cancer” [Clinical Lung Cancer 26 (2025) 573-582]},
  journal = {Clinical Lung Cancer},
  year = {2026},
  volume = {27},
  number = {9},
  pages = {51},
  doi = {10.1016/j.cllc.2026.09.008}
}
Kostenlos starten →